| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |